Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in India and South Korea20-02-2018
20-02-2018
Suven gets product patents from Aripo and South Korea
Suven Life Sciences on Wednesday announced the grant of a product patent from Aripo (AP4415) and one product patent from South Korea (10-18087922) corresponding to new chemical ent31-01-2018
Press Release / Media Release
Suven Life Sciences secures Product Patents in Aripo and South Korea31-01-2018
Press Release / Media Release
Suven Revenue up by 11.85%; PAT up by 15.38% for 9 months ended December' 201730-01-2018
Board approves Dividend
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 30th January, 2018, has taken on record the Standalone Un-audited Financial Results of the Company under Ind AS for the quarter and nine months ended 31st December, 2017 and approved the following matters....30-01-2018
Board declares Interim Dividend
Suven Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 30, 2018, inter alia, has approved the following: 1. The Board declared an interim dividend of Rs. 1.50 per equity share of face value Rs. 1/- each for the year 2017-2018.2. The above said dividend will be paid on and from February 15, 2018.30-01-2018
Notification Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2017
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 30th January, 2018, has taken on record the Standalone Un-audited Financial Results of the Company under Ind AS for the quarter and nine months ended 31st December, 2017 and approved the following matters....30-01-2018
Analyst / Investor Meet - Intimation
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Wednesday, January 31, 2018 at 12:30 p.m. IST to discuss the Un-audited Financial Results for the Q3 Financial Year 2018, to be declared on 30th January, 2018.25-01-2018
Fixes Record Date for Interim Dividend
Suven Life Sciences Ltd has informed BSE that the Company has fixed February 07, 2018 as the Record Date for the purpose of Payment of Interim Dividend.20-01-2018